FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4245632000> ?p ?o ?g. }

• W4245632000 abstract "Background Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction to colonisation of the lungs with the fungus Aspergillus fumigatus and affects around 10% of people with cystic fibrosis. ABPA is associated with an accelerated decline in lung function. High doses of corticosteroids are the main treatment for ABPA; although the long‐term benefits are not clear, their many side effects are well‐documented. A group of compounds, the azoles, have activity against Aspergillus fumigatus and have been proposed as an alternative treatment for ABPA. Of this group, itraconazole is the most active. A separate antifungal compound, amphotericin B, has been employed in aerosolised form to treat invasive infection with Aspergillus fumigatus, and may have potential for the treatment of ABPA. Antifungal therapy for ABPA in cystic fibrosis needs to be evaluated. Objectives The review aimed to test the hypotheses that antifungal interventions for the treatment of ABPA in cystic fibrosis: 1. improve clinical status compared to placebo or standard therapy (no placebo); 2. do not have unacceptable adverse effects. If benefit was demonstrated, we aimed to assess the optimal type, duration and dose of antifungal therapy. Search methods We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register which comprises references identified from comprehensive electronic database searches, handsearches of relevant journals and abstract books of conference proceedings. In addition, pharmaceutical companies were approached. Date of the most recent search of the Group's Trials Register: 26 November 2009. Selection criteria Published or unpublished randomised controlled trials, where antifungal treatments have been compared to either placebo or no treatment, or where different doses of the same treatment have been used in the treatment of ABPA in people with cystic fibrosis. Data collection and analysis Two trials were identified by the searches; one is currently awaiting classification and one was not judged eligible for inclusion in the review. Main results No completed randomised controlled trials were included. Authors' conclusions At present, there are no randomised controlled trials to evaluate the use of antifungal therapies for the treatment of ABPA in people with cystic fibrosis. Trials with clear outcome measures are needed to properly evaluate this potentially useful treatment for cystic fibrosis." @default.
• W4245632000 created "2022-05-12" @default.
• W4245632000 creator A5024306774 @default.
• W4245632000 creator A5049835765 @default.
• W4245632000 date "2000-10-23" @default.
• W4245632000 modified "2023-10-18" @default.
• W4245632000 title "Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis" @default.
• W4245632000 cites W1560650821 @default.
• W4245632000 cites W1946256898 @default.
• W4245632000 cites W1974893215 @default.
• W4245632000 cites W1988195179 @default.
• W4245632000 cites W1997775131 @default.
• W4245632000 cites W1997855218 @default.
• W4245632000 cites W1998979526 @default.
• W4245632000 cites W2005581514 @default.
• W4245632000 cites W2005894108 @default.
• W4245632000 cites W2075425014 @default.
• W4245632000 cites W2077424676 @default.
• W4245632000 cites W2082792877 @default.
• W4245632000 cites W2120902620 @default.
• W4245632000 cites W2122670779 @default.
• W4245632000 cites W2135649656 @default.
• W4245632000 cites W2136496779 @default.
• W4245632000 cites W2150817537 @default.
• W4245632000 cites W2153044469 @default.
• W4245632000 cites W92943117 @default.
• W4245632000 doi "https://doi.org/10.1002/14651858.cd002204" @default.
• W4245632000 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11034746" @default.
• W4245632000 hasPublicationYear "2000" @default.
• W4245632000 type Work @default.
• W4245632000 citedByCount "13" @default.
• W4245632000 countsByYear W42456320002012 @default.
• W4245632000 countsByYear W42456320002013 @default.
• W4245632000 countsByYear W42456320002014 @default.
• W4245632000 countsByYear W42456320002016 @default.
• W4245632000 countsByYear W42456320002022 @default.
• W4245632000 crossrefType "reference-entry" @default.
• W4245632000 hasAuthorship W4245632000A5024306774 @default.
• W4245632000 hasAuthorship W4245632000A5049835765 @default.
• W4245632000 hasConcept C126322002 @default.
• W4245632000 hasConcept C141105273 @default.
• W4245632000 hasConcept C142724271 @default.
• W4245632000 hasConcept C159654299 @default.
• W4245632000 hasConcept C16005928 @default.
• W4245632000 hasConcept C177713679 @default.
• W4245632000 hasConcept C197934379 @default.
• W4245632000 hasConcept C203014093 @default.
• W4245632000 hasConcept C204787440 @default.
• W4245632000 hasConcept C27081682 @default.
• W4245632000 hasConcept C2776391196 @default.
• W4245632000 hasConcept C2776938444 @default.
• W4245632000 hasConcept C2777071850 @default.
• W4245632000 hasConcept C2778871687 @default.
• W4245632000 hasConcept C2779548794 @default.
• W4245632000 hasConcept C2779629538 @default.
• W4245632000 hasConcept C2779787849 @default.
• W4245632000 hasConcept C2780690907 @default.
• W4245632000 hasConcept C71924100 @default.
• W4245632000 hasConceptScore W4245632000C126322002 @default.
• W4245632000 hasConceptScore W4245632000C141105273 @default.
• W4245632000 hasConceptScore W4245632000C142724271 @default.
• W4245632000 hasConceptScore W4245632000C159654299 @default.
• W4245632000 hasConceptScore W4245632000C16005928 @default.
• W4245632000 hasConceptScore W4245632000C177713679 @default.
• W4245632000 hasConceptScore W4245632000C197934379 @default.
• W4245632000 hasConceptScore W4245632000C203014093 @default.
• W4245632000 hasConceptScore W4245632000C204787440 @default.
• W4245632000 hasConceptScore W4245632000C27081682 @default.
• W4245632000 hasConceptScore W4245632000C2776391196 @default.
• W4245632000 hasConceptScore W4245632000C2776938444 @default.
• W4245632000 hasConceptScore W4245632000C2777071850 @default.
• W4245632000 hasConceptScore W4245632000C2778871687 @default.
• W4245632000 hasConceptScore W4245632000C2779548794 @default.
• W4245632000 hasConceptScore W4245632000C2779629538 @default.
• W4245632000 hasConceptScore W4245632000C2779787849 @default.
• W4245632000 hasConceptScore W4245632000C2780690907 @default.
• W4245632000 hasConceptScore W4245632000C71924100 @default.
• W4245632000 hasLocation W42456320001 @default.
• W4245632000 hasLocation W42456320002 @default.
• W4245632000 hasOpenAccess W4245632000 @default.
• W4245632000 hasPrimaryLocation W42456320001 @default.
• W4245632000 hasRelatedWork W2067840748 @default.
• W4245632000 hasRelatedWork W2074149293 @default.
• W4245632000 hasRelatedWork W2119800013 @default.
• W4245632000 hasRelatedWork W2126521105 @default.
• W4245632000 hasRelatedWork W2143036279 @default.
• W4245632000 hasRelatedWork W2156755613 @default.
• W4245632000 hasRelatedWork W2416781282 @default.
• W4245632000 hasRelatedWork W2484496567 @default.
• W4245632000 hasRelatedWork W2509805462 @default.
• W4245632000 hasRelatedWork W3021009728 @default.
• W4245632000 isParatext "false" @default.
• W4245632000 isRetracted "false" @default.
• W4245632000 workType "reference-entry" @default.